STOCK TITAN
  1. Home
  2. Sec-filings
  3. CRWV
  4. [144] CoreWeave, Inc. SEC Filing

CRWV (NASDAQ: CRWV) insider plans 12,500-share stock sale and details 10b5-1 trades

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of CRWV common stock submitted a notice of proposed sale under Form 144. The filing lists 12,500 common shares to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $898,500.00, originally acquired as Founders Shares on February 25, 2019.

The notice also details prior Rule 10b5-1 trading plan sales of CRWV common stock during the past three months by Brannin McBee, Meghan Bennett and several related trusts and entities, each showing dates, share amounts and dollar values of these completed sales.

Positive

  • None.

Negative

  • None.
Shares proposed for sale 12,500 shares Common stock to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services
Aggregate market value of proposed sale $898,500.00 Value associated with 12,500 CRWV common shares listed in the Form 144
Acquisition date of Founders Shares 02/25/2019 Date the 12,500 common shares were acquired as Founders Shares
Example 10b5-1 sale 07/20/2026 144,000 shares; $10,819,094.40 Rule 10b5-1 sale of CRWV common stock for Brannin McBee on 07/20/2026
Example 10b5-1 sale 06/22/2026 40,000 shares; $4,451,020.00 Rule 10b5-1 sale for CANIS MAJOR 2025 GRAT on 06/22/2026
Non-10b5-1 sale 05/20/2026 3,683 shares; $367,637.06 Sale of CRWV common stock for Brannin McBee on 05/20/2026
Form 144 regulatory
"144: Securities Information Common | Morgan Stanley Smith Barney LLC"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
10b5-1 Sales regulatory
"10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave."
10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.
Founders Shares financial
"Common | 02/25/2019 | Founders Shares | Issuer"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
Executive Financial Services financial
"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"
IRREVOCABLE TR LLC financial
"CANIS MAJOR 2024 IRREVOCABLE TR LLC 290 W Mt. Pleasant Ave."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What does the CRWV Form 144 filing disclose?
The Form 144 for CRWV discloses a proposed sale of 12,500 common shares with an aggregate market value of $898,500.00, along with a detailed history of prior Rule 10b5-1 plan sales in the past three months.

How many CRWV shares are proposed to be sold in this Form 144?
The filer indicates an intent to sell 12,500 shares of CRWV common stock. These shares are reported with an aggregate market value of $898,500.00 and are identified as Founders Shares acquired on February 25, 2019.

What is the reported market value of the CRWV shares to be sold?
The Form 144 reports an aggregate market value of $898,500.00 for the 12,500 CRWV common shares proposed for sale. This value is listed in the securities information section associated with the planned disposition.

Which prior CRWV stock sales are listed in the past three months section?
The filing lists multiple Rule 10b5-1 sales of CRWV common stock during the past three months by Brannin McBee, Meghan Bennett and several Canis Major and Canis Minor trusts, each entry showing the trade date, share count and dollar amount sold.

Are CRWV shares sold under a Rule 10b5-1 trading plan?
Yes. Many past three-month transactions are labeled as 10b5-1 Sales of CRWV common shares. Each such entry identifies the selling person or entity, the specific date, the number of shares sold and the dollar proceeds for that sale.

On which exchange are the CRWV shares referenced in the Form 144 traded?
The securities information section identifies the CRWV common shares as traded on NASDAQ. This designation appears alongside the reported 12,500 shares to be sold and their $898,500.00 aggregate market value.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR